Tuberculosis drug interaction study
Part of Infections clinical trials.
This study looks at how tuberculosis medications interact with each other or with other drugs you may be taking. The goal is to make sure your treatment is as safe and effective as possible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with tuberculosis (TB).
- You are receiving care at the TB clinic at Kasr Alainy Hospital in Cairo.
- You or your guardian agree to take part in the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how common TB medicines are absorbed, used, and cleared in children who are already taking treatment for tuberculosis. It may help doctors choose safer and more effective doses for children.
This study tests how a new TB drug (Sudapyridine) interacts with two common medicines: itraconazole (an antifungal) and rifampin (a TB treatment). It also looks at how food affects the drug. The study is for healthy Chinese adults to find the safest dosing.
This study is testing new combinations of drugs to treat tuberculosis (TB) in the lungs. It aims to find a more effective and shorter treatment, and you may benefit from receiving these new drugs while helping advance TB research.
This study tests if adding the cholesterol drug atorvastatin to standard TB treatment can help clear the infection faster. It looks at how the body processes the drugs and how well they work together.
This study follows patients being treated for tuberculosis with standard medications to see how well the treatment works and what side effects occur. Your medical records and check-ups help doctors understand which treatments are most effective.
This trial tests new combinations of TB medicines for people with active lung TB that is sensitive to standard drugs. It aims to find safer, shorter treatments that work just as well or better than current options.
Hear when a new Drug-drug Interaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.